Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0XYXAL
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
DCLL9718S
|
|||||
| Synonyms |
Anti-CLL1 THIOMAB-PBD conjugate; Anti-CLL1 THIOMAB-PBD conjugate (Genentech); DCLL97 18S; RG-6109; RG 6109; RG6109; DCLL9718S
Click to Show/Hide
|
|||||
| Organization |
Genentech, Inc.; Roche Holding AG; University of Texas MD Anderson Cancer Center
|
|||||
| Drug Status |
Phase 1 (Terminated)
|
|||||
| Indication |
In total 1 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
2
|
|||||
| Antibody Name |
MCLL0517A
|
Antibody Info | ||||
| Antigen Name |
C-type lectin domain family 12 member A (CLEC12A)
|
Antigen Info | ||||
| Payload Name |
PBD dimer
|
Payload Info | ||||
| Therapeutic Target |
Human Deoxyribonucleic acid (hDNA)
|
Target Info | ||||
| Conjugate Type |
Random Cysteines
|
|||||
| TTD ID | ||||||
